DrugsControl Media Services

News Detail

Covaxin gets SEC nod for use in children aged 2-18 years (12-10-2021)

New Delhi, 12 Oct 2021: Bharat Biotech’s Covaxin, the vaccine against coronavirus disease (Covid-19), has received the recommendation of a subject expert committee (SEC) for use in children between the ages 2 to 18. The Drug Controller General of India (DGCI) will give the ......
View Details

Source : Hindustan Times

Related News